150 related articles for article (PubMed ID: 19628188)
1. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
[TBL] [Abstract][Full Text] [Related]
2. Iso-osmolar vs low-osmolar contrast agents for coronary optical coherence tomography: a blinded prospective randomized controlled study.
Kostantinis S; Mastrodemos O; Stanberry L; Sandoval Y; Allana SS; Mutlu D; Simsek B; Rempakos A; Karacsonyi J; Alexandrou M; Okeson BK; Burke MN; Rangan BV; Brilakis ES
J Invasive Cardiol; 2024 Jun; 36(6):. PubMed ID: 38446023
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Leukocytoclastic Vasculitis Induced by the Iodinated Contrast Media Iohexol With Cross-Reactivity to Iodixanol.
Mija LA; Désy D; Filion CA; Picard M
J Allergy Clin Immunol Pract; 2024 May; 12(5):1346-1347. PubMed ID: 38551524
[No Abstract] [Full Text] [Related]
4. NMR-based metabolomic analysis of plasma from elderly patients with CVD before and after using contrast media.
Du Q; Jiang T; Yuan Q; Bai Y; Lin D; Liu D
Heliyon; 2024 May; 10(9):e30434. PubMed ID: 38737248
[TBL] [Abstract][Full Text] [Related]
5. Detection of iodixanol-induced allergic reaction signals in Chinese inpatients: a multi-center retrospective database study using prescription sequence symmetry analysis.
Zhang D; Yang X; Yang Z; Sun W; Chen S; Xu L
Front Pharmacol; 2024; 15():1298021. PubMed ID: 38601462
[TBL] [Abstract][Full Text] [Related]
6. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.
Biondi-Zoccai G; Lotrionte M; Thomsen HS; Romagnoli E; D'Ascenzo F; Giordano A; Frati G
Int J Cardiol; 2014 Mar; 172(2):375-80. PubMed ID: 24502883
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
Zhang BC; Wu Q; Wang C; Li DY; Wang ZR
J Cardiol; 2014 Apr; 63(4):260-8. PubMed ID: 24397991
[TBL] [Abstract][Full Text] [Related]
8. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS
Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
[TBL] [Abstract][Full Text] [Related]
10. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis.
McDonald JS; McDonald RJ; Comin J; Williamson EE; Katzberg RW; Murad MH; Kallmes DF
Radiology; 2013 Apr; 267(1):119-28. PubMed ID: 23319662
[TBL] [Abstract][Full Text] [Related]
11. The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Reed MC; Moscucci M; Smith DE; Share D; LaLonde T; Mahmood SA; D'Haem C; McNamara R; Greenbaum A; Gurm HS
J Invasive Cardiol; 2010 Oct; 22(10):467-72. PubMed ID: 20944185
[TBL] [Abstract][Full Text] [Related]
12. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?
McDonald RJ; McDonald JS; Bida JP; Carter RE; Fleming CJ; Misra S; Williamson EE; Kallmes DF
Radiology; 2013 Apr; 267(1):106-18. PubMed ID: 23360742
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
Laskey W; Aspelin P; Davidson C; Rudnick M; Aubry P; Kumar S; Gietzen F; Wiemer M;
Am Heart J; 2009 Nov; 158(5):822-828.e3. PubMed ID: 19853704
[TBL] [Abstract][Full Text] [Related]
15. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
[TBL] [Abstract][Full Text] [Related]
16. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
Davenport MS; Khalatbari S; Dillman JR; Cohan RH; Caoili EM; Ellis JH
Radiology; 2013 Apr; 267(1):94-105. PubMed ID: 23360737
[TBL] [Abstract][Full Text] [Related]
17. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.
Cigarroa RG; Lange RA; Williams RH; Hillis LD
Am J Med; 1989 Jun; 86(6 Pt 1):649-52. PubMed ID: 2729314
[TBL] [Abstract][Full Text] [Related]
18. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
Zhang J; Jiang Y; Rui Q; Chen M; Zhang N; Yang H; Zhou Y
Medicine (Baltimore); 2018 May; 97(18):e0617. PubMed ID: 29718868
[TBL] [Abstract][Full Text] [Related]
19. Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media.
Azzalini L; Vilca LM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Demir OM; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A
Int J Cardiol; 2018 Dec; 273():69-73. PubMed ID: 30196995
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
